Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veerle Baekelandt

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Nature|February 4, 2026
Immune cells from the gut drive development of Parkinson's disease in the brainVeerle Baekelandt
NPJ Parkinson'S Disease|October 23, 2024
Depletion of ATP13A2 in adult brain induces a Parkinsonian phenotype in mice and non-human primatesVeerle Baekelandt
Nature Structural & Molecular Biology|May 5, 2016
α-synuclein folds: the cards are on the tableWouter Peelaerts, Veerle Baekelandt
Journal of Neurochemistry|March 1, 2016
ɑ-Synuclein strains and the variable pathologies of synucleinopathiesWouter Peelaerts, Veerle Baekelandt
Neurobiology of Disease|July 5, 2022
The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseasesGeorge Tsafaras, Veerle Baekelandt
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 13, 2023
⍺-Synuclein Structural Diversity and the Cellular Environment in ⍺-Synuclein Transmission Models and HumansWouter Peelaerts, Veerle Baekelandt
Frontiers in Genetics|November 27, 2014
Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of ParkinsonismJean-Marc Taymans, Veerle Baekelandt
Frontiers in Neuroscience|May 16, 2020
Multiple-Hit Hypothesis in Parkinson's Disease: LRRK2 and InflammationDiego Cabezudo, Veerle Baekelandt, Evy Lobbestael
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|February 2, 2018
LRRK2 Phosphorylation: Behind the ScenesTina De Wit, Veerle Baekelandt, Evy Lobbestael
Frontiers in Molecular Neuroscience|August 15, 2014
Regulation and targeting of enzymes mediating Parkinson's disease pathogenesis: focus on Parkinson's disease kinases, GTPases, and ATPasesJean-Marc Taymans, Veerle Baekelandt, Kirsten Harvey
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Nature|February 4, 2026
Immune cells from the gut drive development of Parkinson's disease in the brainVeerle Baekelandt
NPJ Parkinson'S Disease|October 23, 2024
Depletion of ATP13A2 in adult brain induces a Parkinsonian phenotype in mice and non-human primatesVeerle Baekelandt
Nature Structural & Molecular Biology|May 5, 2016
α-synuclein folds: the cards are on the tableWouter Peelaerts, Veerle Baekelandt
Journal of Neurochemistry|March 1, 2016
ɑ-Synuclein strains and the variable pathologies of synucleinopathiesWouter Peelaerts, Veerle Baekelandt
Neurobiology of Disease|July 5, 2022
The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseasesGeorge Tsafaras, Veerle Baekelandt
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 13, 2023
⍺-Synuclein Structural Diversity and the Cellular Environment in ⍺-Synuclein Transmission Models and HumansWouter Peelaerts, Veerle Baekelandt
Frontiers in Genetics|November 27, 2014
Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of ParkinsonismJean-Marc Taymans, Veerle Baekelandt
Frontiers in Neuroscience|May 16, 2020
Multiple-Hit Hypothesis in Parkinson's Disease: LRRK2 and InflammationDiego Cabezudo, Veerle Baekelandt, Evy Lobbestael
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|February 2, 2018
LRRK2 Phosphorylation: Behind the ScenesTina De Wit, Veerle Baekelandt, Evy Lobbestael
Frontiers in Molecular Neuroscience|August 15, 2014
Regulation and targeting of enzymes mediating Parkinson's disease pathogenesis: focus on Parkinson's disease kinases, GTPases, and ATPasesJean-Marc Taymans, Veerle Baekelandt, Kirsten Harvey
Pageof 18